Current Report · Items 5.02, 9.01 · 8-K
Vaso Corporation
VASOOTCEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02(e) On May 4, 2026, Vaso Corporation (“Vaso”) entered into an agreement with Peter Castle, President of VasoTechnology Inc., a wholly-owned subsidiary of Vaso. The agreement provides an opportunity to earn an incentive payment for Mr. Castle’s participation in helping Vaso achieve specified corporate outcomes relating to potential strategic initiatives (the “Objectives”).…
Company context
Vaso Corporation is a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services and proprietary medical products. The Company operates through three principal business segments: IT, professional sales services and equipment.
Current securities
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
Item
5.02(e)
On May 4, 2026, Vaso Corporation (“Vaso”)
entered into an agreement with Peter Castle, President of VasoTechnology Inc., a wholly-owned subsidiary of Vaso. The agreement provides
an opportunity to earn an incentive payment for Mr. Castle’s participation in helping Vaso achieve specified corporate outcomes
relating to potential strategic initiatives (the “Objectives”). If the Objectives are achieved within the time period specified
in the agreement, and subject to his continued compliance with the agreement, Mr. Castle will be paid $175,000. Otherwise, he will not
receive any portion of the incentive amount.